Tagraxofusp Administered Concomitantly with Intrathecal Chemotherapy in Patients with BPDCN who Either Have or are Considered High-risk to Develop CNS Disease is a Safe and Effective Treatment Strategy: An Italian Multicenter Experience

Autor: Rivoli, Giulia *, Beltrami, Germana *, Raiola, Anna M. *, Paley, Carole *, Riggi, Marcello *, Dominietto, Alida *, Angelucci, Emanuele
Zdroj: In Blood 15 November 2022 140 Supplement 1:13271-13272
Databáze: ScienceDirect